Trokide Vertical-Haler
Trokide Vertical-Haler® is a dry powder inhaler (DPI) which is therapeutically equivalent to Spiriva® HandiHaler® for formulation and device characteristics.1
Trokide® (tiotropium bromide) indications
Trokide Vertical-Haler® is indicated as a maintenance bronchodilator treatment to relieve symptoms of patients with chronic obstructive pulmonary disease (COPD).
Instructions for reporting Adverse Events can be found in the footer of this page. Prescribing information is available here.
Unlock Savings With Trokide®
Annual estimated reduction in prescribing spend of £28.8m for the NHS in the UK by using Trokide® as first choice tiotropium bromide inhaler.2
Equivalence to Spiriva® HandiHaler®
Trokide Vertical-Haler® is equivalent to Spiriva® HandiHaler® in terms of:1
- active ingredient
- delivered dose per actuation
- inhaling technique
- therapeutic effect and device characteristics
Demonstration devices are also available
Device Characteristics
1. Cap | 2. Mouthpiece | 3. Base
4. Push button | 5. Capsule chamber/nest
Implementation Support
We’re here to support you all the way through the implementation process, with formulary support documents, cost calculators for your area, letters as well as materials for both healthcare professionals and patients.
Formulary Review Process:
- Formulary application support document
Request document - Tailored cost-savings report detailing savings for your area
Request report - Price & stock commitment letter
- Pharmacy letter – introduction to formulary
For Healthcare Professionals:
- Product information leaflets
- Demonstration devices for training
Request demo devices
For Patients
- Device demonstration video
- Leaflet with instructions for use
- Letter to explain change in inhaler
- Website
Visit patient website
Committed to measuring and reducing carbon emissions
STADA UK is committed to reducing carbon emissions for Trokide Vertical-Haler® using industry emissions as a benchmark.
Trokide Vertical-Haler® is a dry-powder inhaler. Increasing use of DPIs instead of pMDIs (pressurised metered dose inhaler) helps to reduce CO2 emissions for the NHS.3
Only 4 devices per year are needed with Trokide Vertical-Haler® vs. 12 with Braltus® 1,4 helping to reduce plastic waste.
References
- STADA UK Ltd. 2024. Data on File. Trokide Pharmaceutical Development.
- STADA UK Ltd. 2024. Data on File. Based on indicative NHS list prices and IQVIA data. Access date: April 2025.
- NHS England. 2021. Delivering a ‘Net Zero’ National Health Service. Access date: April 2025.
- Teva UK Ltd. 2019. Summary of Product Characteristics. Braltus Tiotropium (Braltus) 10mcg inhalation powder. Access date: April 2025.
